DSpace logo

Browsing by Author Mahesh, R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 37 to 56 of 112 < previous   next >
Issue DateTitleAuthor(s)
2005-02Cancer chemotherapy-induced nausea and vomiting: role of mediators, development of drugs and treatment methodsMahesh, R.
2013Chronic unpredictable stressors can produce a situation similar to human depression and such animal models can be used for the preclinical evaluation of antidepressants. The 5-HT3 receptor antagonists modulate serotonergic pathways and show antidepressant-like effect in various animal models of depressionMahesh, R.
2011-04Citric acid: An efficient and green catalyst for rapid one pot synthesis of quinoxaline derivatives at room temperatureMahesh, R.
2010Demographic study on disease prevalence and their treatment pattern in a local hospital of a semi-urban communityMahesh, R.
2010-02Depressant-like effects of parthenolide in a rodent behavioural antidepressant test batteryMahesh, R.
2010Depression Associated Disorders: Comorbidity, eurobiological and eurobehavioural LinkMahesh, R.
2009-12Depression-like and anxiety-like behavioural aftermaths of impact accelerated traumatic brain injury in rats: A model of comorbid depression and anxiety?Mahesh, R.
2009Depression: Current Therapy and ovel Anti-depressant Drug TargetsMahesh, R.
2019-11Design, synthesis and evaluation of 2-(4-(substituted benzoyl)-1,4-diazepan-1-yl)-N-phenylacetamide derivatives as a new class of falcipain-2 inhibitorsMahesh, R.
2013-12Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2-Methoxy 1, 8 Naphthyridine 3-Carboxamides as 5-HT3 Receptor AntagonistsMahesh, R.
2010-11Design, synthesis and structure–activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depressionMahesh, R.
2014-06Design, Synthesis, and Pharmacological Evaluation of Novel 2-(4-substituted piperazin-1-yl)1, 8 Naphthyridine 3-Carboxylic Acids as 5-HT3 Receptor Antagonists for the Management of DepressionMahesh, R.
2015Diabetes-associated depression: The serotonergic system as a novel multifunctional targetMahesh, R.
2011-02Discovery of new anti-depressants from structurally novel 5-HT3 receptor antagonists: Design, synthesis and pharmacological evaluation of 3-ethoxyquinoxalin-2-carboxamidesMahesh, R.
2017-02Dynamin Functions and Ligands: Classical Mechanisms BehindMahesh, R.
2014Effect of (4a) a novel 5-HT3 receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests batteryMahesh, R.
2015-04Effect of a novel 5-HT3 receptor antagonist 4i, in corticosterone-induced depression-like behavior and oxidative stress in miceMahesh, R.
2013Effect of a novel 5-HT3 receptor antagonist carboxamide, 3-methoxy-N-p-tolylquinoxalin-2-carboxamide (QCM-4) on the acute and chronic rodent models of depressionMahesh, R.
2014-05Effect of a Selective Cyclooxygenase Type 2 Inhibitor Celecoxib on Depression Associated with Obesity in Mice: An Approach Using Behavioral TestsMahesh, R.
2010-12Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depressionMahesh, R.; Yadav, Shushil K.